Physician profile
Beth A Walmer
NPI 1932259777
$2,708.52
in general payments reported to CMS, 2019-2025
16 companies · $763 in 2025
The $763 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $222 · 2021: $181 · 2022: $301 · 2023: $553 · 2024: $434 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $555.78 | 2022-2025 | Biotrue One Day, Infuse, Vyzulta |
| Alcon Vision LLC | $544.34 | 2019-2025 | Rocklatan, Tryptyr, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $282.62 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $269.46 | 2019-2025 | Acuvue |
| Coopervision INC. | $237.77 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $198.63 | 2021-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $155.18 | 2025 | Xdemvy |
| Allergan, INC. | $105.85 | 2020-2022 | |
| Dompe US, INC. | $85.77 | 2025 | Oxervate |
| Biotissue Holdings INC. | $71.84 | 2024-2025 | |
| Abbvie INC. | $54.29 | 2022-2025 | Alphagan P, Lumigan |
| Oyster Point Pharma, INC. | $49.89 | 2024 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $28.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.32 | 2021-2022 | |
| Glaukos Corporation | $23.97 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $17.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Walmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.